Matching-Adjusted Indirect Comparison of the Efficacy of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Beyond Week 16. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 Apr. 19];8(1):s319. Available from: https://skin.dermsquared.com/skin/article/view/2400